Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Prevalence and antibiotic resistance of commensal Streptococcus pneumoniae in nine European countries.

Yahiaoui RY, den Heijer CDj, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA, Schellevis FG, Stobberingh EE; APRES Study Team.

Future Microbiol. 2016 Jun;11:737-44. doi: 10.2217/fmb-2015-0011. Epub 2016 May 18.

PMID:
27191588
2.

Evaluation of phenotypic and molecular methods for identification of Streptococcus pneumoniae.

Yahiaoui RY, den Heijer CD, Wolfs P, Bruggeman CA, Stobberingh EE.

Future Microbiol. 2016;11(1):43-50. doi: 10.2217/fmb.15.124. Epub 2015 Dec 17.

PMID:
26673889
3.

Confirmation of high specificity of an automated enzyme immunoassay test for serological diagnosis of syphilis: retrospective evaluation versus results after implementation.

van Dommelen L, Hoebe CJ, van Tiel FH, Thijs C, Goossens VJ, Bruggeman CA, van Loo IH.

Sex Transm Dis. 2015 Mar;42(3):120-2. doi: 10.1097/OLQ.0000000000000240.

PMID:
25668642
4.

Impact of same-day antibiotic susceptibility testing on time to appropriate antibiotic treatment of patients with bacteraemia: a randomised controlled trial.

Beuving J, Wolffs PF, Hansen WL, Stobberingh EE, Bruggeman CA, Kessels A, Verbon A.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):831-8. doi: 10.1007/s10096-014-2299-0. Epub 2014 Dec 20.

PMID:
25527447
5.

Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community.

van Bijnen EM, Paget WJ, den Heijer CD, Stobberingh EE, Bruggeman CA, Schellevis FG; APRES Study Team.

BMC Fam Pract. 2014 Oct 25;15:175. doi: 10.1186/s12875-014-0175-8.

6.

Haemophilus influenzae increases the susceptibility and inflammatory response of airway epithelial cells to viral infections.

Gulraiz F, Bellinghausen C, Bruggeman CA, Stassen FR.

FASEB J. 2015 Mar;29(3):849-58. doi: 10.1096/fj.14-254359. Epub 2014 Nov 19.

PMID:
25411435
7.

Vancomycin dosing in neutropenic patients.

Haeseker MB, Croes S, Neef C, Bruggeman CA, Stolk LM, Verbon A.

PLoS One. 2014 Nov 12;9(11):e112008. doi: 10.1371/journal.pone.0112008. eCollection 2014.

8.

Comparison of three different techniques for the isolation of viral RNA in sputum.

Vanspauwen MJ, Wolffs PF, Franssen FM, Bruggeman CA, Wouters EF, Linssen CF.

J Clin Virol. 2014 Oct;61(2):265-9. doi: 10.1016/j.jcv.2014.07.012. Epub 2014 Jul 28.

PMID:
25132398
9.

Molecular epidemiology of Pneumocystis jiroveci in human immunodeficiency virus-positive and -negative immunocompromised patients in The Netherlands.

Vanspauwen MJ, Knops VE, Bruggeman CA, van Mook WN, Linssen CF.

J Med Microbiol. 2014 Oct;63(Pt 10):1294-302. doi: 10.1099/jmm.0.076257-0. Epub 2014 Jul 24.

PMID:
25060971
10.

Developments for improved diagnosis of bacterial bloodstream infections.

Loonen AJ, Wolffs PF, Bruggeman CA, van den Brule AJ.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1687-702. doi: 10.1007/s10096-014-2153-4. Epub 2014 May 22. Review.

PMID:
24848132
11.

Microbiology of surgical site infections after gastrointestinal surgery in the south region of The Netherlands.

Ramcharan AA, den Heijer CD, Smeets EE, Rouflart MM, van Tiel FH, Bruggeman CA, Breukink SO, Tordoir JH, Baeten CG, Stobberingh EE.

Future Microbiol. 2014;9(3):291-8. doi: 10.2217/fmb.13.169.

PMID:
24762304
12.

Efficacy of IFN-λ1 to protect human airway epithelial cells against human rhinovirus 1B infection.

Gulraiz F, Bellinghausen C, Dentener MA, Reynaert NL, Gaajetaan GR, Beuken EV, Rohde GG, Bruggeman CA, Stassen FR.

PLoS One. 2014 Apr 21;9(4):e95134. doi: 10.1371/journal.pone.0095134. eCollection 2014.

13.

Evidence-based primary care treatment guidelines for skin infections in Europe: a comparative analysis.

van Bijnen EM, Paget J, den Heijer CD, Stobberingh EE, Bruggeman CA, Schellevis FG; APRES study team.

Eur J Gen Pract. 2014 Dec;20(4):294-300. doi: 10.3109/13814788.2013.872621. Epub 2014 Jan 23.

PMID:
24456348
14.

The host immune response contributes to Haemophilus influenzae virulence.

Geelen TH, Gaajetaan GR, Wouters EF, Rohde GG, Franssen FM, Grauls GE, Stobberingh EE, Bruggeman CA, Stassen FR.

Respir Med. 2014 Jan;108(1):144-52. doi: 10.1016/j.rmed.2013.08.005. Epub 2013 Sep 5.

15.

Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study.

Haeseker MB, Pijpers E, Dukers-Muijrers NH, Nelemans P, Hoebe CJ, Bruggeman CA, Verbon A, Goossens VJ.

Immun Ageing. 2013 Jul 23;10(1):30. doi: 10.1186/1742-4933-10-30.

16.

Mimivirus is not a frequent cause of ventilator-associated pneumonia in critically ill patients.

Vanspauwen MJ, Schnabel RM, Bruggeman CA, Drent M, van Mook WN, Bergmans DC, Linssen CF.

J Med Virol. 2013 Oct;85(10):1836-41. doi: 10.1002/jmv.23655. Epub 2013 Jul 16.

PMID:
23861144
17.

Antimicrobial resistance among respiratory Haemophilus influenzae isolates from pulmonology services over a six-year period.

Geelen TH, Stassen FR, Hoogkamp-Korstanje JA, Bruggeman CA, Stobberingh EE; Antimicrobial Resistance Surveillance Group.

Scand J Infect Dis. 2013 Aug;45(8):606-11. doi: 10.3109/00365548.2013.796088. Epub 2013 Jun 9.

PMID:
23746341
18.

A real-time PCR-based semi-quantitative breakpoint to aid in molecular identification of urinary tract infections.

Hansen WL, van der Donk CF, Bruggeman CA, Stobberingh EE, Wolffs PF.

PLoS One. 2013 Apr 23;8(4):e61439. doi: 10.1371/journal.pone.0061439. Print 2013.

19.

The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study.

den Heijer CD, Penders J, Donker GA, Bruggeman CA, Stobberingh EE.

PLoS One. 2013;8(3):e60497. doi: 10.1371/journal.pone.0060497. Epub 2013 Mar 29.

20.

Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study.

den Heijer CD, van Bijnen EM, Paget WJ, Pringle M, Goossens H, Bruggeman CA, Schellevis FG, Stobberingh EE; APRES Study Team.

Lancet Infect Dis. 2013 May;13(5):409-15. doi: 10.1016/S1473-3099(13)70036-7. Epub 2013 Mar 6. Erratum in: Lancet Infect Dis. 2013 Dec;13(12):1011. Flemming, Douglas [corrected to Fleming, Douglas].

PMID:
23473661
21.

Improving sexual health for HIV patients by providing a combination of integrated public health and hospital care services; a one-group pre- and post test intervention comparison.

Dukers-Muijrers NH, Somers C, Hoebe CJ, Lowe SH, Niekamp AM, Oude Lashof A, Bruggeman CA, Vrijhoef HJ.

BMC Public Health. 2012 Dec 27;12:1118. doi: 10.1186/1471-2458-12-1118.

22.

Oral and topical antibiotic prescriptions for children in general practice.

de Bont EG, van Loo IH, Dukers-Muijrers NH, Hoebe CJ, Bruggeman CA, Dinant GJ, Cals JW.

Arch Dis Child. 2013 Mar;98(3):228-31. doi: 10.1136/archdischild-2012-303134. Epub 2012 Dec 25.

PMID:
23268371
23.

Influence of temperature, medium, and storage duration on Chlamydia trachomatis DNA detection by PCR.

van Dommelen L, Wolffs PF, van Tiel FH, Dukers N, Herngreen SB, Bruggeman CA, Hoebe CJ.

J Clin Microbiol. 2013 Mar;51(3):990-2. doi: 10.1128/JCM.02631-12. Epub 2012 Dec 19.

24.

Trends in antibiotic prescribing in adults in Dutch general practice.

Haeseker MB, Dukers-Muijrers NH, Hoebe CJ, Bruggeman CA, Cals JW, Verbon A.

PLoS One. 2012;7(12):e51860. doi: 10.1371/journal.pone.0051860. Epub 2012 Dec 12.

25.

Interferon-β induces a long-lasting antiviral state in human respiratory epithelial cells.

Gaajetaan GR, Geelen TH, Vernooy JH, Dentener MA, Reynaert NL, Rohde GG, Beuken EV, Grauls GE, Bruggeman CA, Stassen FR.

J Infect. 2013 Feb;66(2):163-9. doi: 10.1016/j.jinf.2012.11.008. Epub 2012 Nov 28.

PMID:
23201152
26.

Pre-analytical sample treatment and DNA extraction protocols for the detection of bacterial pathogens from whole blood.

Hansen WL, Bruggeman CA, Wolffs PF.

Methods Mol Biol. 2013;943:81-90. doi: 10.1007/978-1-60327-353-4_4.

PMID:
23104282
27.

Infections with mimivirus in patients with chronic obstructive pulmonary disease.

Vanspauwen MJ, Franssen FM, Raoult D, Wouters EF, Bruggeman CA, Linssen CF.

Respir Med. 2012 Dec;106(12):1690-4. doi: 10.1016/j.rmed.2012.08.019. Epub 2012 Sep 16.

28.

Impact of bacterial colonization on exhaled inflammatory markers in wheezing preschool children.

van de Kant KD, Klaassen EM, van Aerde KJ, Damoiseaux J, Bruggeman CA, Stelma FF, Stobberingh EE, Muris JW, Jöbsis Q, van Schayck OC, Dompeling E.

J Breath Res. 2012 Dec;6(4):046001. doi: 10.1088/1752-7155/6/4/046001. Epub 2012 Sep 18. Erratum in: J Breath Res. 2012 Dec;6(4):049601.

PMID:
22990010
29.

Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region.

Hackert VH, van der Hoek W, Dukers-Muijrers N, de Bruin A, Al Dahouk S, Neubauer H, Bruggeman CA, Hoebe CJ.

Clin Infect Dis. 2012 Dec;55(12):1591-9. doi: 10.1093/cid/cis734. Epub 2012 Aug 23.

PMID:
22918992
30.

Response to 'human adenovirus-36 and childhood obesity'.

Goossens VJ, Bruggeman CA.

Pediatr Obes. 2012 Apr;7(2):e19-20. doi: 10.1111/j.2047-6310.2011.00044.x. No abstract available.

PMID:
22434761
31.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.

Rijnders MI, Wolffs PF, Hopstaken RM, den Heyer M, Bruggeman CA, Stobberingh EE.

J Antimicrob Chemother. 2012 May;67(5):1176-80. doi: 10.1093/jac/dkr590. Epub 2012 Jan 30.

PMID:
22290345
32.

Human metapneumovirus in bronchoalveolar lavage fluid of critically ill patients with suspected pneumonia.

Vanspauwen MJ, van Mook WN, Bruggeman CA, Bergmans DC, Linssen CF.

Intensive Care Med. 2012 Apr;38(4):728-9. doi: 10.1007/s00134-011-2446-3. Epub 2012 Jan 5. No abstract available.

PMID:
22218810
33.

CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNβ-dependent and -independent way.

Gaajetaan GR, Geelen TH, Grauls GE, Bruggeman CA, Stassen FR.

Antiviral Res. 2012 Jan;93(1):39-47. doi: 10.1016/j.antiviral.2011.10.015. Epub 2011 Oct 25.

PMID:
22057305
34.

The appropriateness of prescribing antibiotics in the community in Europe: study design.

van Bijnen EM, den Heijer CD, Paget WJ, Stobberingh EE, Verheij RA, Bruggeman CA, Pringle M, Goossens H, Schellevis FG.

BMC Infect Dis. 2011 Oct 28;11:293. doi: 10.1186/1471-2334-11-293.

35.

The type I interferon response during viral infections: a "SWOT" analysis.

Gaajetaan GR, Bruggeman CA, Stassen FR.

Rev Med Virol. 2012 Mar;22(2):122-37. doi: 10.1002/rmv.713. Epub 2011 Oct 3. Review.

PMID:
21971992
36.

Is pre-emptive strict isolation of patients at high risk of colonization with MRSA still required in low-prevalence countries?

van Tiel FH, Smeets EE, Bruggeman CA, Nelemans P, Stobberingh EE.

J Hosp Infect. 2011 Nov;79(3):272-4. doi: 10.1016/j.jhin.2011.04.025. Epub 2011 Jun 29. No abstract available.

PMID:
21719148
37.

Compartmentalization of acyclovir-resistant varicella zoster virus: implications for sampling in molecular diagnostics.

Brink AA, van Gelder M, Wolffs PF, Bruggeman CA, van Loo IH.

Clin Infect Dis. 2011 Apr 15;52(8):982-7. doi: 10.1093/cid/cir079.

PMID:
21460310
38.

Replacing traditional diagnostics of fecal viral pathogens by a comprehensive panel of real-time PCRs.

Wolffs PF, Bruggeman CA, van Well GT, van Loo IH.

J Clin Microbiol. 2011 May;49(5):1926-31. doi: 10.1128/JCM.01925-10. Epub 2011 Mar 23.

39.

A 12 year (1998-2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals.

van der Donk CF, Beisser PS, Hoogkamp-Korstanje JA, Bruggeman CA, Stobberingh EE; Antibiotic Resistance Surveillance Group.

J Antimicrob Chemother. 2011 Apr;66(4):855-8. doi: 10.1093/jac/dkq538. Epub 2011 Jan 26.

PMID:
21393165
40.

Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia?

Vanspauwen MJ, Linssen CF, Bruggeman CA, Jacobs JA, Drent M, Bergmans DC, van Mook WN.

Crit Care. 2011;15(1):R14. doi: 10.1186/cc9418. Epub 2011 Jan 11.

41.

Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods.

Loonen AJ, Jansz AR, Kreeftenberg H, Bruggeman CA, Wolffs PF, van den Brule AJ.

Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):337-42. doi: 10.1007/s10096-010-1090-0. Epub 2010 Oct 24.

42.

Molecular probes for diagnosis of clinically relevant bacterial infections in blood cultures.

Hansen WL, Beuving J, Bruggeman CA, Wolffs PF.

J Clin Microbiol. 2010 Dec;48(12):4432-8. doi: 10.1128/JCM.00562-10. Epub 2010 Oct 20.

43.

Alarmingly poor performance in Chlamydia trachomatis point-of-care testing.

van Dommelen L, van Tiel FH, Ouburg S, Brouwers EE, Terporten PH, Savelkoul PH, Morré SA, Bruggeman CA, Hoebe CJ.

Sex Transm Infect. 2010 Oct;86(5):355-9. doi: 10.1136/sti.2010.042598.

PMID:
20876754
44.

Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.

Croes S, Beisser PS, Neef C, Bruggeman CA, Stobberingh EE.

Antimicrob Agents Chemother. 2010 Sep;54(9):3907-12. doi: 10.1128/AAC.01811-09. Epub 2010 Jul 6.

45.

Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review.

Vainas T, Sayed S, Bruggeman CA, Stassen FR.

Drugs Today (Barc). 2009 Nov;45 Suppl B:165-72. Review.

PMID:
20011710
46.

The inflammatory aspects of Chlamydia pneumoniae-induced brain infection.

Boelen E, Steinbusch HW, Bruggeman CA, Stassen FR.

Drugs Today (Barc). 2009 Nov;45 Suppl B:159-64. Review.

PMID:
20011709
47.

TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection.

Ouburg S, Lyons JM, Land JA, den Hartog JE, Fennema JS, de Vries HJ, Bruggeman CA, Ito JI, Peña AS, Lundberg PS, Morré SA.

Drugs Today (Barc). 2009 Nov;45 Suppl B:83-93.

PMID:
20011699
48.

TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility.

den Hartog JE, Lyons JM, Ouburg S, Fennema JS, de Vries HJ, Bruggeman CA, Ito JI, Peña AS, Land JA, Morré SA.

Drugs Today (Barc). 2009 Nov;45 Suppl B:75-82.

PMID:
20011698
49.

Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort.

Goossens VJ, deJager SA, Grauls GE, Gielen M, Vlietinck RF, Derom CA, Loos RJ, Rensen SS, Buurman WA, Greve JW, van Baak MA, Wolffs PF, Bruggeman CA, Hoebe CJ.

Obesity (Silver Spring). 2011 Jan;19(1):220-1. doi: 10.1038/oby.2009.452. Epub 2009 Dec 10.

50.

Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.

Onuta G, van Ark J, Rienstra H, Boer MW, Klatter FA, Bruggeman CA, Zeebregts CJ, Rozing J, Hillebrands JL.

Atherosclerosis. 2010 Apr;209(2):393-402. doi: 10.1016/j.atherosclerosis.2009.10.020. Epub 2009 Oct 22.

PMID:
19913790

Supplemental Content

Loading ...
Support Center